1. State – Equity Concern « Uzpharmsanoat » Welcomes guests and participants of Uzbek-U.S.A Business Forum “ Investment Opportunities of the pharmaceutical industry in the Republic of Uzbekistan and prospects of cooperation with the United States of America” ” Tashkent 17-18 august 2012 Tashkent 17-18 august 2012

2. Structure of pharmaceutical industry Enterprises for the production of medicines and medicinal products (130) Scientific institutions and scientific research institute on development and production of substances, organizations on training of specialists of the high and middle classes Enterprises for the wholesale of medicines and medicinal products (more than 200) Drugstores over 8000

3. 3 Ensuring the needs of population on the nomenclature of manufactured pharmaceutical products, %

4. 4 Main goals and aims of SJC “Uzpharmsanoat”  Organizations of production of original and generic drugs;  Saturation the market’s needs with high quality, export-oriented, accessible drugs;  Matching national production with international standards quality control ISO, GMP;  Organization to attract foreign investment to create new production socially important groups of drugs;  Organization to attract foreign investment to create new production socially important groups of drugs ; Organisation of export of medicinal products and medical products

5. -The volume of pharmaceutical market in 2011 totaled more than 700.0 million USD. -Share of national producers accounted for 22% or 150.0 mln USD. Provision of pharmaceutical market of Uzbekistan

6. Opportunities for export to bordering countries Knowing the location of Uzbekistan should be noted that the export potential is great as, for example: Kazakhstan imports annually about 600 million USD; Tajikistan is approximately 116 million USD; Kyrgyzstan is approximately 100 million USD; Turkmenistan - 140 million USD; Afghanistan - 200 million USD.

7. The ratio of registered medicines in the Republic of Uzbekistan on 01.01.2012g. Total - 6236 items

8. The list of U.S. companies and The list of U.S. companies and Pharmaceutical groups № Name of U.S. companies Amount of registered drugs Pharmaceutical groups 1 Ortho-Clinical Diagnostics Inc 1 The agent which is mainly applied in obstetrics and gynecology 2 Unipharm Inc 26 Stimulator of a trophicity of tissues and neogenesis, Vitamins, Agent for correction of metabolic processes, Agent for treatment of disturbances of a peripheric circulation, an iodine Preparation, Adaptogen and all-excitant 3 KV Pharmaceuticals Co, Gedeon Richter PLC США 1 Antifungal agent

9. The list of U.S. companies and The list of U.S. companies and Pharmaceutical groups №Name of U.S.companies Amount of registered drugs Pharmaceutical groups 1 Sagmel, Inc.9 The agent applied in the koloproktology, Antifungal agent, Vitamins, Agent for treatment of diseases of ENT organ. 2 Mission Pharmacal Company 1 The agent applied at an urolithiasis 3 Eli Lilly and Company 3 Medicines for Insulin

10. The capital structure of pharmaceutical companies (in mln. USD)

11. 11 Exempt of VAT and custom duties: Import of raw materials for pharmaceutical production; Import of raw materials for pharmaceutical production; Technologic equipment; Technologic equipment; Settled technologic equipment is exempt of property tax for 2 years. Settled technologic equipment is exempt of property tax for 2 years. Benefits and insensitive for foreign investors

12. 12 Together with the company «Merck» arranged market research of pharmaceutical market to identify potential therapeutic areas, with insufficient drug level to supply through local production. The company «Con Technologies Corporation» has expressed a desire to participate in the project for the production of pharmaceutical products in the SIZ "Angren" Cooperation with US companies

13. Total cost of the project of - 28 mln.USD; Annual production capacity – 1,0 mln conventional units. in a year; Payback period – 6 years; Profitability – 29 %; Created workplaces – 100. « The organization of production of preparations for treatment of oncologic diseases» The proposed location - SIZ "Angren“ Note: could be changed after consultation with the foreign partner

14. Total cost of the project of - 25 mln.USD; - Annual production capacity – 2 mln. packs in a year; Payback period – 6 years; Profitability – 27 %; Created workplaces – 100. «The organization of production of preparations for treatment of cardiovascular diseases» The proposed location - SIZ "Angren“ Note: could be changed after consultation with the foreign partner

15. « The organization of production of preparations for treatment of endocrine diseases » Total cost of the project of-12 mln.USD; Annual capacity – 5,0 mln. conventional units. in a year; Payback period – 5 years; Profitability – 20 %; Created workplaces – 50.. The proposed location - SIZ "Angren“ Note: could be changed after consultation with the foreign partner

16. « The organization of production of preparations for treatment of psychoneurological diseases » Total cost of the project of-30 mln.USD; Annual capacity – 15,0 mln conventional units. in a year; Payback period – 5 years; Profitability – 27 %; Created workplaces – 50.. The proposed location - SIZ "Angren“ Note: could be changed after consultation with the foreign partner

17. www.uzpharmsanoat.uz e-mail: pochta@uzpharmsanoat.uz; ufs@sarkor.uz Thank you!